The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments

Virology Journal

Volumn 7, Issue , 2010, Pages

  Jia, Chun Shi ^a   Liu, Jiang Ning ^a   Li, Wan Bo ^a   Ma, Chun Mei ^a   Lin, Shu Zhu ^a   Hao, Yi ^a   Gao, Xue Zhong ^b   Liu, Xiao Lin ^b   Xu, Yan Feng ^a   Zhang, Lian Feng ^a   Qin, Chuan ^a  

^a BEIJING HOSPITAL   (China)

^b Fuyang People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS ANTIBODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CHILD; CONTROLLED STUDY; CROSS REACTION; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MOUSE; NONHUMAN; SEROLOGY; ANIMAL; BRAIN; BRAIN LEVEL; ENTEROVIRUS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; NEWBORN; VIROLOGY;

HUMAN ENTEROVIRUS 71; MUS; PROKARYOTA;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD-BRAIN BARRIER; BRAIN; BRAIN CHEMISTRY; ENTEROVIRUS A, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED ICR;

EID: 77649277062     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-47     Document Type: Article

References (54)

1. An apparently new enterovirus isolated from patients with disease of the central nervous system. NJ Schmidt EH Lennette HH Ho, J Infect Dis 1974 129 304 309 4361245
2. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. BA Brown MA Pallansch, Virus Res 1995 39 195 205 10.1016/0168-1702(95)00087-9 8837884
3. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. BA Brown MS Oberste JP Alexander Jr ML Kennett MA Pallansch, J Virol 1999 73 9969 9975 10559310
4. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. B Ortner CW Huang D Schmid I Mutz G Wewalka F Allerberger JY Yang HP Huemer, J Med Virol 2009 81 317 324 10.1002/jmv.21374 19107980
5. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. AL Fowlkes S Honarmand C Glaser S Yagi D Schnurr MS Oberste L Anderson MA Pallansch N Khetsuriani, J Infect Dis 2008 198 1685 1691 10.1086/592988 18959496
6. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. S Diedrich A Weinbrecht E Schreier, Arch Virol 2009 154 1139 1142 10.1007/s00705-009-0413-x 19506798
7. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. K Mizuta C Abiko T Murata Y Matsuzaki T Itagaki K Sanjoh M Sakamoto S Hongo S Murayama K Hayasaka, J Clin Microbiol 2005 43 6171 6175 10.1128/JCM.43.12.6171-6175.2005 16333123
8. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. SS Gau LY Chang LM Huang TY Fan YY Wu TY Lin, Pediatrics 2008 122 452 458 10.1542/peds.2007-3799 18606624
9. Enterovirus 71 Infection of Human Dendritic Cells. YW Lin SW Wang YY Tung SH Chen, Exp Biol Med (Maywood) 2009 19596831
10. Primary detection of pathogen from children with hand, foot, and mouth disease in Beijing, 2007. JP Zhu ZG Xu H Chen X Zhang DY Fan J Wang, Bing Du Xue Bao 2009 25 23 28 19437882
11. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. NZ Ding XM Wang SW Sun Q Song SN Li CQ He, Virus Res 2009 19540282
12. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. YW Lin KC Chang CM Kao SP Chang YY Tung SH Chen, J Virol 2009 83 6477 6483 10.1128/JVI.00434-09 19386699
13. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. YF Wang CT Chou HY Lei CC Liu SM Wang JJ Yan IJ Su JR Wang TM Yeh SH Chen CK Yu, J Virol 2004 78 7916 7924 10.1128/JVI.78.15.7916- 7924.2004 15254164
14. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Y Nishimura M Shimojima Y Tano T Miyamura T Wakita H Shimizu, Nat Med 2009 15 794 797 10.1038/nm.1961 19543284
15. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. CS Chen YC Yao SC Lin YP Lee YF Wang JR Wang CC Liu HY Lei CK Yu, J Virol 2007 81 8996 9003 10.1128/JVI.00236-07 17567704
16. A murine oral enterovirus 71 infection model with central nervous system involvement. YC Chen CK Yu YF Wang CC Liu IJ Su HY Lei, J Gen Virol 2004 85 69 77 10.1099/vir.0.19423-0 14718621
17. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. N Nagata T Iwasaki Y Ami Y Tano A Harashima Y Suzaki Y Sato H Hasegawa T Sata T Miyamura H Shimizu, J Gen Virol 2004 85 2981 2989 10.1099/vir.0.79883-0 15448361
18. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. N Nagata H Shimizu Y Ami Y Tano A Harashima Y Suzaki Y Sato T Miyamura T Sata T Iwasaki, J Med Virol 2002 67 207 216 10.1002/jmv.2209 11992581
19. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. M Arita N Nagata N Iwata Y Ami Y Suzaki K Mizuta T Iwasaki T Sata T Wakita H Shimizu, J Virol 2007 81 9386 9395 10.1128/JVI.02856-06 17567701
20. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. H Wang J Sun H Goldstein, J Virol 2008 82 7591 7600 10.1128/JVI.00768-08 18508884
21. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. GL Bowman JA Kaye M Moore D Waichunas NE Carlson JF Quinn, Neurology 2007 68 1809 1814 10.1212/01.wnl.0000262031.18018.1a 17515542
22. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Y Ganor H Goldberg-Stern D Amrom T Lerman-Sagie VI Teichberg D Pelled AH Futerman BB Zeev M Freilinger D Verheulpen, et al. Clin Dev Immunol 2004 11 241 252 10.1080/17402520400001736 15559370
23. Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. Z Wu F Yang R Zhao L Zhao D Guo Q Jin, J Virol Methods 2009 159 233 238 10.1016/j.jviromet.2009.04.002 19490979
24. Molecular confirmation of enterovirus type 71 infection: a post-mortem study of two cases. Y Yang H Wang J Du XS Zhao EC Gong ZF Gao J Zheng, Zhonghua Bing Li Xue Za Zhi 2009 38 258 262 19575899
25. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. LY Chang TY Lin KH Hsu YC Huang KL Lin C Hsueh SR Shih HC Ning MS Hwang HS Wang CY Lee, Lancet 1999 354 1682 1686 10.1016/S0140-6736(99)04434-7 10568570
26. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. T Fujimoto M Chikahira S Yoshida H Ebira A Hasegawa A Totsuka O Nishio, Microbiol Immunol 2002 46 621 627 12437029
27. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. LW Ang BK Koh KP Chan LT Chua L James KT Goh, Ann Acad Med Singapore 2009 38 106 112 19271036
28. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. LY Chang SH Hsia CT Wu YC Huang KL Lin TY Fang TY Lin, Pediatr Infect Dis J 2004 23 327 332 10.1097/00006454-200404000-00010 15071287
29. Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. LY Chang CY Lee CL Kao TY Fang CY Lu PI Lee LM Huang, J Formos Med Assoc 2007 106 173 176 10.1016/S0929-6646(09)60236-9 17339164
30. Neurodevelopment and cognition in children after enterovirus 71 infection. LY Chang LM Huang SS Gau YY Wu SH Hsia TY Fan KL Lin YC Huang CY Lu TY Lin, N Engl J Med 2007 356 1226 1234 10.1056/NEJMoa065954 17377160
31. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. CY Chen YC Chang CC Huang CC Lui KW Lee SC Huang, AJNR Am J Neuroradiol 2001 22 200 205 11158910
32. Neurologic complications of enterovirus 71 infection in children: lessons from this Taiwan epidemic. CC Huang, Acta Paediatr Taiwan 2001 42 5 7 11270188
33. Emerging viral infections of the central nervous system: part 1. KL Tyler, Arch Neurol 2009 66 939 948 10.1001/archneurol.2009.153 19667214
34. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. KT Wong B Munisamy KC Ong H Kojima N Noriyo KB Chua BB Ong K Nagashima, J Neuropathol Exp Neurol 2008 67 162 169 10.1097/nen.0b013e318163a990 18219253
35. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. TC Wu YF Wang YP Lee JR Wang CC Liu SM Wang HY Lei IJ Su CK Yu, J Virol 2007 81 10310 10315 10.1128/JVI.00372-07 17626076
36. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. YC Chung MS Ho JC Wu WJ Chen JH Huang ST Chou YC Hu, Vaccine 2008 26 1855 1862 18329759
37. Expression of recombinant VP1 protein of enterovirus 71 and development of serological assay for detection of EV71 infection. BP Zhou WL Liu JJ Xie XC Chen LM Xu Y Tan YX Liu GL Yang, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008 22 492 494 19544656
38. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. HL Chen JY Huang TW Chu TC Tsai CM Hung CC Lin FC Liu LC Wang YJ Chen MF Lin CM Chen, Vaccine 2008 26 2882 2889 10.1016/j.vaccine.2008.03.041 18450335
39. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. DG Foo RX Ang S Alonso VT Chow SH Quak CL Poh, Clin Microbiol Infect 2008 14 286 288 10.1111/j.1469-0691.2007.01904.x 18076666
40. Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits. LA Sivasamugham MJ Cardosa WS Tan K Yusoff, J Med Virol 2006 78 1096 1104 10.1002/jmv.20668 16789020
41. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. CH Chiu C Chu CC He TY Lin, Microbes Infect 2006 8 1671 1678 10.1016/j.micinf.2006.01.021 16815726
42. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. HF Chen MH Chang BL Chiang ST Jeng, Vaccine 2006 24 2944 2951 10.1016/j.vaccine.2005.12.047 16448730
43. Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. AL Olsen JD Morrey DF Smee RW Sidwell, Antiviral Res 2007 75 104 112 10.1016/j.antiviral.2006.11.013 17223204
44. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. G Zanoni R Navone C Lunardi G Tridente C Bason S Sivori R Beri M Dolcino E Valletta R Corrocher A Puccetti, PLoS Med 2006 3 358 10.1371/journal.pmed.0030358 16984219
45. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. L Bataller KA Kleopa GF Wu JE Rossi MR Rosenfeld J Dalmau, J Neurol Neurosurg Psychiatry 2007 78 381 385 10.1136/jnnp.2006.100644 16980333
46. Virus-mediated autoimmunity in Multiple Sclerosis. N Grigoriadis GM Hadjigeorgiou, J Autoimmune Dis 2006 3 1 10.1186/1740-2557-3-1 16504001
47. Observations on recent studies showing increased co-occurrence of autoimmune diseases. S Sloka, J Autoimmun 2002 18 251 257 10.1006/jaut.2002.0588 12126638
48. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. J Seissler JJ de Sonnaville NG Morgenthaler H Steinbrenner D Glawe UY Khoo-Morgenthaler MS Lan AL Notkins RJ Heine WA Scherbaum, Diabetologia 1998 41 891 897 10.1007/s001250051004 9726590
49. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. YC Lin CN Wu SR Shih MS Ho, Vaccine 2002 20 2485 2493 10.1016/S0264-410X(02)00182-2 12057603
50. hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. JY Lin SR Shih M Pan C Li CF Lue V Stollar ML Li, J Virol 2009 83 6106 6114 10.1128/JVI.02476-08 19339352
51. Genotype analysis of enterovirus type 71 detected from patients with hand-foot-mouth disease in Shenzhen. YQ He H Yang LL Li J Tan L Zhou LS Mao F Yang JJ Liu X Lv, Zhonghua Liu Xing Bing Xue Za Zhi 2008 29 790 793 19103116
52. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
53. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. M Arita Y Ami T Wakita H Shimizu, J Virol 2008 82 1787 1797 10.1128/JVI.01798-07 18057246
54. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. W Ito Y Kurosawa, J Biol Chem 1993 268 20668 20675 8376416